Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Frontiers in Endocrinology|May 25, 2026
The CHK1 inhibitor Prexasertib is effective against <i>in vitro</i> models of aggressive thyroid carcinomas with defective p53 functionAlessandro Manzo, Elisa Stellaria Grassi, Maria Orietta Borghi, et al.
Clinical Endocrinology|July 27, 2004
BRAF mutations in an Italian cohort of thyroid cancersLaura Fugazzola, Deborah Mannavola, Valentina Cirello, et al.
International Journal of Cancer|June 25, 2015
Fetal cell microchimerism in papillary thyroid cancer: A role in the outcome of the diseaseValentina Cirello, Carla Colombo, Michela Perrino, et al.
Frontiers in Oncology|September 19, 2022
Thyroid cancer harboring <i>PTEN</i> and <i>TP53</i> mutations: A peculiar molecular and clinical case reportCarla Colombo, Gabriele Pogliaghi, Delfina Tosi, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2005
Total iodide organification defect: clinical and molecular characterization of an Italian familyLaura Fugazzola, Deborah Mannavola, Maria Cristina Vigone, et al.
Hormones (Athens, Greece)|November 18, 2014
Diabetes mellitus in a girl with thyroid hormone resistance syndrome: a little recognized interaction between the two diseasesStefano Stagi, Cristina Manoni, Valentina Cirello, et al.
Endocrine-Related Cancer|July 20, 2007
Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia?Uberta Verga, Stefano Ferrero, Leonardo Vicentini, et al.
International Journal of Cancer|October 27, 2009
Fetal cell microchimerism in papillary thyroid cancer: studies in peripheral blood and tissuesValentina Cirello, Michela Perrino, Carla Colombo, et al.
Infection|March 1, 2023
Fetal cell microchimerism and susceptibility to COVID-19 disease in womenValentina Cirello, Marina Lugaresi, Alessandro Manzo, et al.
European Journal of Endocrinology|October 17, 2013
The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptorGuia Vannucchi, Danila Covelli, Irene Campi, et al.
Pageof 5